Swiss Biotech Day 2023

Apr 20 2023

Scailyte is happy to announce that Sarah Carl, our Director of Data Science, will be a panellist at the Swiss Biotech Association‘s Swiss Biotech Day 2023 on April 24, 2023, from 15:45 to 16:30 in Room Montreal at the Congress Center Basel. The panel topic is “Powering Precision Medicine Using Multi-Level Data”, and Sarah will be sharing her expertise on this important topic in the context of Scailyte’s multi-omics discovery platform.

The panel will explore the advantages, promises, and obstacles of utilising multi-omics, clinical and other molecular data to advance precision medicine. Despite revealing tremendous insights into complex diseases such as cancer, cardiovascular disorders, neuropathological diseases, and rare diseases, genomics alone often fails to identify important biomarkers for best therapy decisions.

Join us and leading Swiss digital life science companies as we delve into the potential of multi-level data to improve precision medicine. Don’t miss the opportunity to hear from experts in the field, including Sarah Carl. We can’t wait to see you there!

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

ISCT 2023

Diana Stoycheva and Filipa Teixeira will be attending the ISCT 2023 Annual Meeting from 31st May to ...

Future Labs Live 2023

Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...

The psychological and economic impact of endometriosis

We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...

Jan Lichtenberg joins Scailyte's Board of Directors

Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...

Challenges and opportunities for innovation in Endometriosis

Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...